National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 75058 [2022-26612]

Download as PDF 75058 Federal Register / Vol. 87, No. 234 / Wednesday, December 7, 2022 / Notices confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cardiovascular and Surgical Devices. Date: December 16, 2022. Time: 7:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Willard Wilson, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301–867–5309, willard.wilson@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: December 2, 2022. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–26587 Filed 12–6–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES ddrumheller on DSK6VXHR33PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID SBIR Phase II 19:54 Dec 06, 2022 Jkt 259001 Dated: December 2, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–26612 Filed 12–6–22; 8:45 am] ‘‘Substance Abuse and Mental Health Services Administration’’ following ‘‘DEPARTMENT OF HEALTH AND HUMAN SERVICES’’ and ‘‘Document Identifier: OS–0990–New’’ is corrected to read ‘‘Document Identifier: 0930– 0092’’. 2. On page 71341, in the second column, correct the ‘‘ADDRESSES’’ and ‘‘FOR FURTHER INFORMATION CONTACT’’ captions to read: ADDRESSES: Submit your comments to Carlos.Grahamcommathhs.gov or by calling (240) 276–0361. FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting information, please include the document identifier 0930–0092, and project title for reference, to Carlos Graham, Reports Clearance Officer; email: CarlosGraham@hhs.gov, or call (240) 276–0361. Carlos Graham, Reports Clearance Officer. [FR Doc. 2022–26508 Filed 12–6–22; 8:45 am] BILLING CODE 4162–20–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Document Identifier: 0930–0092] [Internal Agency Docket No. FEMA–4673– DR; Docket ID FEMA–2022–0001] Agency Information Collection Request; 60-Day Public Comment Request; Correction Florida; Amendment No. 12 to Notice of a Major Disaster Declaration Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. ACTION: Notice; correction. AGENCY: National Institutes of Health VerDate Sep<11>2014 Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required). Date: January 13, 2023. Time: 9:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room RML 31/ 31118A, Rockville, MD 20892 (Virtual Meeting). Contact Person: Dylan Paul Flather, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room RML 31/31118A, Rockville, MD 20852, (406) 802–6209, dylan.flather@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) The Substance Abuse and Mental Health Services Administration published a document in the Federal Register on November 22, 2022, concerning request for comments on Confidentiality of Substance Use Disorder Patient Records. The document only listed the Department of Health and Human Services in the headings and contained an incorrect Document Identifier and contact for further information or submission of public comments. This document corrects those errors. Comments on the information collect request must be received on or before January 23, 2023. SUPPLEMENTARY INFORMATION: In the Federal Register of November 22, 2022, at 87 FR 71341, in FR Doc. 2022–25343, the following corrections are made: 1. On page 71341, in the second column, in the headings, add SUMMARY: PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: This notice amends the notice of a major disaster declaration for the State of Florida (FEMA–4673–DR), dated September 29, 2022, and related determinations. DATES: This amendment was issued November 10, 2022. FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street SW, Washington, DC 20472, (202) 646–2833. SUPPLEMENTARY INFORMATION: The notice of a major disaster declaration for the State of Florida is hereby amended to include the following area among those areas determined to have been adversely affected by the event declared a major disaster by the President in his declaration of September 29, 2022. SUMMARY: Martin County for debris removal [Category A] and permanent work [Categories C–G] (already designated for emergency protective measures [Category B], including direct E:\FR\FM\07DEN1.SGM 07DEN1

Agencies

[Federal Register Volume 87, Number 234 (Wednesday, December 7, 2022)]
[Notices]
[Page 75058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26612]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation Cooperative Agreement (U44 Clinical Trial Required).
    Date: January 13, 2023.
    Time: 9:00 a.m. to 11:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room RML 31/
31118A, Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Dylan Paul Flather, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room RML 31/
31118A, Rockville, MD 20852, (406) 802-6209, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 2, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26612 Filed 12-6-22; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.